Clinical efficacy of edarovone combined with kailldinogenase in treating patients with progressive cerebral in-farction
ZHANG Ze-jian
FU Fei-huan
LIN Jin
Abstract：Objective To explore the clinical efficacy of edarovone combined with kailldinogenase in treating patients with progressive cerebral infarction .Methods Ninety patients with acute progressive cerebral infarction trea-ted in the people′s hospital of Anxi county recently were randomly divided into treatment group (45 cases) and control group(45 cases).All the patients received the routine treatment such as aspirin for anticoagulation ,atorvastatin for reducing lipid,shuxuetong for improving circulation ,and so on.On the basis of above treatment ,the control group was treated with edarovone ,while the treatment group was treated with edarovone combined with kailldinogenase .The neu-rological injury ,blood rheology changes and clinical efficacy before and after treatment were observed and compared . Results The clinical efficacy of treatment group was better than that of the control group ( P<0.01 ) .The neurologic deficit scale ,hemorheology indexes after treatment declined significantly in two groups ( P<0.05 or P<0.01 ) , but the declined extent in the treatment group was greater than that in the control group ( P<0.01 ) .Conclusion Edaro-vone combined with kailldinogenase shows good clinical efficacy in treating progressive cerebral infaretion .
Keywords：EdarovoneKailldinogenaseProgressive cerebral infarction
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 141-143 )